North America Ultrasound Devices Market Report

To learn more about this report, Download Free Sample Report

North America Ultrasound Devices Market Size

The North America ultrasound devices market size was valued at USD 2.18 billion in 2025. The ultrasound devices market in North America is estimated to grow from USD 2.29 billion in 2026 to USD 3.36 billion in 2034, growing at a CAGR of 4.9% from 2026 to 2034.

According to the Centers for Disease Control and Prevention, approximately 62 million procedural imaging scans are performed annually in the United States alone, reflecting the modality's centrality in routine diagnostics. According to the American College of Radiology, ultrasound is the primary imaging tool for obstetric care, with over 3.5 million births monitored using sonography each year in the United States and Canada combined. As per data from Statistics Canada, the aging demographic has led to a 20% increase in musculoskeletal disorders among adults over 65, driving demand for point-of-care ultrasound in orthopedic assessments. Furthermore, according to the Society of Diagnostic Medical Sonographers, a persistent shortage of qualified sonographers is accelerating the adoption of artificial intelligence-assisted automated scanning technologies. These clinical and operational realities define the market scope where technological innovation aims to mitigate workforce gaps while enhancing diagnostic precision. The integration of ultrasound into emergency medicine and primary care settings further expands its utility beyond traditional radiology departments, establishing it as a versatile cornerstone of modern medical practice in North America.

MARKET DRIVERS

Rising Prevalence of Chronic Diseases Driving Diagnostic Volume

The escalating burden of chronic diseases across North America is a key factor propelling the North American ultrasound devices market growth. According to the American Heart Association, nearly half of all adults in the United States have some form of cardiovascular disease, necessitating regular echocardiograms and vascular ultrasounds for monitoring and diagnosis. According to the Centers for Disease Control and Prevention, chronic liver disease affects approximately 4.5 million Americans, creating a steady need for abdominal ultrasound screenings to detect fibrosis and cirrhosis early. According to the Public Health Agency of Canada, cancer incidence rates have risen by 10% over the last decade, prompting increased use of ultrasound-guided biopsies for breast, thyroid, and prostate cancers. These pathological trends compel healthcare providers to invest in high-resolution imaging platforms capable of detecting subtle tissue changes. Hospitals are upgrading their fleets to include premium systems with elastography and contrast-enhanced capabilities to meet these complex diagnostic requirements. The shift toward value-based care further incentivizes early detection through non-invasive methods to reduce long-term treatment costs. Consequently, the volume of ultrasound examinations continues to grow independently of economic fluctuations, ensuring robust utilization rates for installed devices across both public and private healthcare facilities.

Expansion of Point of Care Ultrasound in Emergency and Primary Care

The widespread adoption of point-of-care ultrasound in emergency departments and primary care settings is significantly driving market growth by decentralizing diagnostic capabilities. According to the American College of Emergency Physicians, over 80% of emergency departments in the United States now utilize bedside ultrasound for rapid assessment of trauma, cardiac function, and abdominal pain. This shift reduces reliance on centralized radiology suites, decreasing patient wait times and improving clinical decision-making speed. According to the Society of Academic Emergency Medicine, point-of-care ultrasound usage has increased by 25% annually since 2020 as training programs become more accessible to non-radiologist physicians. In primary care, family medicine practitioners are increasingly using handheld devices for immediate evaluation of soft tissue injuries and joint effusions. According to the Canadian Association of Emergency Physicians, rural hospitals in Canada have adopted portable ultrasound units to compensate for limited access to specialist radiologists. This democratization of imaging technology creates a new demand segment for compact, durable, and user-friendly devices. Manufacturers are responding by developing intuitive interfaces and AI-guided protocols that allow generalists to perform accurate scans. This expansion into non-traditional specialties diversifies the customer base and drives volume sales of entry-level and mid-tier ultrasound systems.

MARKET RESTRAINTS

High Capital Costs and Reimbursement Pressures

Significant capital expenditure requirements and evolving reimbursement policies are hampering the ultrasound devices market expansion in North America. According to the Healthcare Financial Management Association, the average cost of a premium cart-based ultrasound system ranges from 100,000 to 250,000 dollars, posing a substantial financial barrier for smaller community hospitals and independent clinics. According to the Centers for Medicare and Medicaid Services, stricter prior authorization requirements have been implemented for certain ultrasound procedures, leading to delayed payments and increased administrative burdens for providers. In Canada, provincial health budgets face constraints that limit the frequency of equipment upgrades, with some regions extending replacement cycles to seven years or more. According to the American Hospital Association, 30% of rural hospitals operate at a financial loss, making it difficult to justify investments in next-generation imaging technologies. Additionally, the shift toward bundled payments encourages cost containment rather than technology acquisition. These financial pressures force healthcare organizations to prioritize essential repairs over new purchases, slowing the adoption of innovative features such as 3D/4D imaging and advanced Doppler capabilities. Consequently, market growth is tempered by budgetary caution, particularly in the public sector where funding is tightly regulated and subject to political fluctuations.

Shortage of Qualified Sonographers and Technicians

A critical deficit of trained diagnostic medical sonographers severely limits the effective utilization of installed ultrasound devices across North America. According to the Society of Diagnostic Medical Sonographers, the United States faces a projected shortfall of 12,000 sonographers by 2030 due to an aging workforce and insufficient training program capacity. This human resource gap results in extended wait times for patients and the underutilization of expensive imaging equipment in many facilities. According to the Canadian Society of Diagnostic Medical Sonographers, vacancy rates for sonography positions have reached 15% in major urban centers like Toronto and Vancouver. Without skilled operators, even the most advanced ultrasound systems cannot deliver optimal diagnostic value, leading to repeated scans and increased operational costs. Hospitals are forced to rely on locum tenens staff or pay overtime, which further strains budgets. The lack of standardized training pathways in some regions exacerbates the issue, creating variability in image quality and diagnostic accuracy. This workforce crisis acts as a structural bottleneck, preventing healthcare providers from maximizing their return on investment in ultrasound technology. Until educational infrastructure expands to meet demand, the full potential of advanced ultrasound capabilities will remain constrained by human capital limitations.

MARKET OPPORTUNITIES

Integration of Artificial Intelligence and Automation

The integration of artificial intelligence and automation into ultrasound platforms is a lucrative opportunity for the North American ultrasound devices market. According to the Radiological Society of North America, AI algorithms can reduce scan time by up to 30% by automatically optimizing image settings and identifying anatomical structures. This capability addresses the sonographer shortage by enabling less experienced users to acquire diagnostic-quality images with greater ease. According to the Food and Drug Administration, several AI-enabled ultrasound applications were approved in recent years, focusing on cardiac measurement and fetal biometry, which streamlines workflow in high-volume settings. Hospitals are increasingly interested in these smart systems as they promise to improve throughput and reduce operator fatigue. According to the American Institute of Ultrasound in Medicine, AI-assisted tools can standardize measurements, reducing inter-observer variability and improving diagnostic confidence. Furthermore, cloud-based connectivity allows for remote expert consultation, enabling rural clinics to access specialist interpretation in real time. This technological leap transforms ultrasound from a purely operator-dependent modality into a data-driven diagnostic tool. Manufacturers who lead in AI development can differentiate their products and capture market share among health systems seeking to optimize operational efficiency and improve patient outcomes through precision medicine.

Growth of Teleultrasound and Remote Diagnostics

The emergence of teleultrasound and remote diagnostic services offers significant opportunities to expand access to care in underserved and rural areas. According to the American Telemedicine Association, the adoption of telehealth services has stabilized at 30% higher than pre-pandemic levels, creating a sustained demand for connected imaging devices. Portable ultrasound units equipped with 5G connectivity allow primary care providers in remote locations to transmit live images to specialists for immediate interpretation. According to the National Rural Health Association, over 60 million Americans live in rural areas with limited access to radiologists, making teleultrasound a vital bridge for equitable care. In Canada, provincial health authorities are piloting programs that link community health centers with urban academic hospitals via secure video links for guided scanning. This model reduces the need for patient travel and accelerates diagnosis for time-sensitive conditions. Manufacturers are developing ruggedized handheld devices specifically designed for telehealth applications, ensuring durability and ease of use in diverse environments. The regulatory framework for remote diagnostics is also evolving to support reimbursement for teleultrasound consultations. This convergence of connectivity and portability opens new revenue streams for device vendors and strengthens their position as enablers of accessible healthcare delivery.

MARKET CHALLENGES

Regulatory Complexity and Cybersecurity Concerns

Navigating the complex regulatory landscape and addressing cybersecurity vulnerabilities pose significant challenges for ultrasound device manufacturers in North America. According to the Food and Drug Administration, medical device cyberattacks increased by 50% in a comparative period, prompting stricter guidelines for software security and data protection. Ultrasound systems increasingly rely on networked connections for image storage and AI processing, making them vulnerable to ransomware and data breaches. According to the Healthcare Information and Management Systems Society, legacy ultrasound devices often lack adequate security patches, exposing hospitals to significant risk. Compliance with the Health Insurance Portability and Accountability Act in the United States and the Personal Information Protection and Electronic Documents Act in Canada requires rigorous encryption and access controls. These requirements increase development costs and prolong time to market for new products. Additionally, the European Union Medical Device Regulation influences global supply chains, forcing manufacturers to maintain dual compliance standards. The complexity of validating AI algorithms as software as a medical device adds another layer of regulatory scrutiny. Manufacturers must balance innovation with robust security measures to maintain trust and avoid costly recalls. Failure to address these challenges can result in reputational damage and legal liabilities, hindering market penetration.

Supply Chain Disruptions and Component Shortages

Persistent supply chain disruptions and shortages of critical electronic components continue to challenge the consistent production and delivery of ultrasound devices. According to the Semiconductor Industry Association, the global shortage of semiconductor chips affected 70% of medical device manufacturers, leading to delayed shipments and increased lead times. Ultrasound systems rely heavily on specialized processors and beamformers, which are subject to geopolitical tensions and trade restrictions. According to the National Association of Manufacturers, logistics costs for medical equipment have risen by 15% due to port congestion and freight volatility. In North America, reliance on Asian suppliers for key components creates vulnerability to regional disruptions such as natural disasters or political instability. Hospitals face uncertainty in planning equipment replacements as delivery timelines extend from months to over a year. This unpredictability forces healthcare providers to hold excess inventory, tying up capital and increasing storage costs. Manufacturers are attempting to mitigate these risks by diversifying suppliers and nearshoring production, but these strategies require significant investment and time. Until supply chains stabilize, the market will remain susceptible to availability issues that constrain growth and frustrate customers seeking timely access to advanced imaging technologies.

REPORT COVERAGE

SEGMENTAL ANALYSIS

By Technology Insights

The diagnostic ultrasound segment had the major share of the North American ultrasound devices market in 2025 and is likely to maintain steady adoption as the primary diagnostic foundation across North America for the next few years. According to the American College of Radiology, diagnostic ultrasound accounts for over 60% of all imaging procedures performed in outpatient settings across the United States. According to the Centers for Disease Control and Prevention, approximately 14 million abdominal ultrasounds are conducted annually to evaluate liver, gallbladder, and kidney health, reflecting the high prevalence of metabolic and digestive disorders. According to the Canadian Association of Radiologists, diagnostic sonography is the preferred initial modality for evaluating thyroid nodules and breast lumps due to its safety profile and cost-effectiveness. This widespread clinical acceptance ensures consistent demand from hospitals and imaging centers. Furthermore, the absence of ionizing radiation makes it suitable for repeated use in chronic disease monitoring, which is increasingly common among the aging population. The versatility of diagnostic systems, which can be equipped with various transducers for different body parts, further cements their leadership. Manufacturers continue to enhance image resolution and processing speed, making these devices indispensable tools for general practitioners and specialists alike, thereby sustaining their dominant market position through volume-driven sales and recurring service contracts.

However, the therapeutic ultrasound is expected to experience accelerated expansion and rising clinical integration over the next few years. According to the American Cancer Society, over 1.9 million new cancer cases were diagnosed in the United States, creating an urgent need for minimally invasive treatment options. High-Intensity Focused Ultrasound offers a precise alternative to surgery for prostate, uterine, and bone tumors with significantly shorter recovery times. The Food and Drug Administration has approved several High-Intensity Focused Ultrasound systems for specific oncological indications, leading to a surge in clinical trials and hospital acquisitions. According to the Canadian Urological Association, a 30% increase in patient inquiries was observed for focal therapy options for localized prostate cancer. This growing patient preference for organ-sparing treatments drives demand for specialized therapeutic devices. Furthermore, the technology is being explored for treating essential tremor and neuropathic pain, expanding its therapeutic scope. As clinical evidence accumulates demonstrating efficacy and safety, more insurance providers are beginning to cover these procedures, reducing financial barriers for patients. This convergence of clinical innovation and patient demand positions therapeutic ultrasound as a dynamic and rapidly expanding sector within the broader market.

By Portability Insights

The trolley- or cart-based ultrasound systems segment accounted for the highest share of the regional market in 2025 and are projected to retain stable institutional demand and steady upgrade cycles over the next few years. According to the American College of Radiology, high-end cart-based systems are mandatory for detailed echocardiograms, abdominal scans, and obstetric evaluations where high resolution and deep tissue penetration are critical. According to the Society of Diagnostic Medical Sonographers, over 80% of hospital radiology departments rely on cart-based units for primary diagnostic workflows. These systems offer larger monitors, advanced processing power, and a wider range of transducer options compared to portable counterparts. According to the Canadian Association of Radiologists, cart-based systems are essential for tertiary care centers handling complex cases such as fetal anomalies and cardiac structural defects. The ergonomic design of these units also supports prolonged scanning sessions, reducing operator fatigue. Furthermore, they integrate seamlessly with hospital information systems and picture archiving and communication systems, ensuring efficient data management. This clinical indispensability ensures that cart-based systems remain the backbone of institutional imaging, driving consistent procurement for new facilities and upgrades in existing ones.

However, the compact and handheld ultrasound devices segment is anticipated to witness rapid mainstream deployment and broadened point-of-care utility over the next few years. According to the American College of Emergency Physicians, the use of handheld ultrasound for rapid trauma assessment has increased by 40%, enabling faster triage and decision-making. According to the Society of Academic Emergency Medicine, handheld devices allow physicians to perform immediate bedside evaluations for pneumothorax, cardiac tamponade, and internal bleeding without waiting for radiology transport. According to the Canadian Association of Emergency Physicians, rural emergency rooms are increasingly equipping staff with handheld units to compensate for a lack of on-site radiologists. The portability and ease of use of these devices empower non-radiologist clinicians to visualize anatomy in real time. Furthermore, the decreasing cost of handheld technology makes it accessible for smaller clinics and private practices. The ability to connect these devices to smartphones and tablets facilitates instant image sharing and teleconsultation. This shift toward decentralized imaging creates a new and rapidly expanding customer base, driving robust growth for compact and handheld segments.

COUNTRY ANALYSIS

U.S Ultrasound Devices Market Analysis

The U.S. had the dominant share of the North American ultrasound devices market in 2025 and is projected to expand steadily, driven by ongoing technological innovations and high healthcare investments over the next few years. The country serves as the primary hub for medical technology innovation and adoption, driven by a large private healthcare sector and significant government funding. According to the Centers for Medicare and Medicaid Services, national health expenditure reached 4.3 trillion dollars, with a substantial portion allocated to diagnostic imaging services. According to the American Hospital Association, over 90% of US hospitals have upgraded their ultrasound fleets in the last five years to incorporate AI and 3D capabilities. The presence of major manufacturers and research institutions fosters a competitive environment that accelerates product development. Regulatory approval through the Food and Drug Administration is rigorous but provides a clear pathway for market entry. Furthermore, the high prevalence of chronic diseases and an aging population ensure sustained demand for both diagnostic and therapeutic ultrasound solutions. This combination of financial resources, technological leadership, and clinical need ensures the United States maintains its dominant position in the regional market.

Canada Ultrasound Devices Market Analysis

Canada is expected to experience consistent market growth supported by public health infrastructure modernization and rising senior care needs over the next few years. The country benefits from a strong network of regional health authorities that coordinate equipment procurement and distribution. According to Statistics Canada, the population aged 65 and older grew by 18%, driving increased demand for musculoskeletal and cardiac ultrasound services. According to the Canadian Institute for Health Information, wait times for MRI and CT scans have led to greater reliance on ultrasound as a faster and more accessible alternative. Provincial governments in Ontario and Quebec have invested heavily in upgrading imaging infrastructure in rural hospitals to reduce geographic disparities. The Medical Devices Bureau of Health Canada ensures strict safety standards while facilitating the introduction of innovative technologies. Additionally, the growing adoption of teleultrasound in remote northern communities is creating new opportunities for portable and connected devices. These factors collectively sustain Canada’s strong standing as a stable and progressive market in the North American landscape.

COMPETITIVE LANDSCAPE

The competition in the North America ultrasound devices market is characterized by intense rivalry among established global manufacturers who strive to capture share through technological innovation and service excellence. Major participants compete on the basis of image quality artificial intelligence capabilities and ease of use rather than price alone. The market features a mix of large conglomerates with broad portfolios and specialized firms focusing on niche applications like handheld or therapeutic ultrasound. Competitive dynamics are influenced by strict regulatory requirements which necessitate rigorous validation and compliance efforts. Companies differentiate themselves by offering integrated digital health solutions that connect ultrasound devices to electronic health records. The rise of point of care testing has intensified competition in the portable segment as more players enter this growing space. Service and support quality remain critical differentiators as healthcare providers seek reliable partners for long term equipment maintenance. This evolving landscape demands continuous adaptation and investment in customer relationships to maintain competitive advantage in a mature yet technologically advancing regional market.

KEY MARKET PLAYERS

Companies playing a dominant role in the North America Ultrasound devices market include

• General Electric Company
• Koninklijke Philips N.V.
• Toshiba Corporation
• Siemens AG
• Hitachi Ltd.
• Samsung Electronics Co., Ltd.
• FUJIFILM Holdings Corporation
• Esaote S.p.A.
• Mindray Medical International Ltd
• Analogic Corporation

Top Players in the Market

GE HealthCare

GE HealthCare maintains a dominant presence in North America by delivering advanced ultrasound solutions across hospital and point of care settings. The company recently launched its Venue Go portable system which integrates artificial intelligence to streamline workflow for emergency and critical care clinicians. GE HealthCare actively collaborates with academic medical centers to develop next generation imaging algorithms that enhance diagnostic accuracy. Its commitment to sustainability is evident in recent initiatives to reduce energy consumption in imaging equipment. The company also expands its service network to ensure rapid support for healthcare providers. These strategic efforts strengthen its reputation as a technology leader while ensuring consistent access to high quality diagnostic tools throughout the region.

Philips

Philips strengthens its position in the North America ultrasound market through innovative imaging platforms and digital health integration. The company recently introduced enhanced versions of its EPIQ and Affiniti systems featuring improved image clarity and automated measurement tools. Philips partners with large health systems to implement cloud based data solutions that facilitate remote collaboration and expert consultation. It invests heavily in research and development to advance therapeutic ultrasound applications for oncology and neurology. The company also focuses on user experience design to reduce operator fatigue during long scanning sessions. These actions enhance clinical efficiency and drive adoption of its premium ultrasound portfolios across diverse healthcare environments.

Siemens Healthineers

Siemens Healthineers serves the North American market with a comprehensive portfolio of diagnostic and therapeutic ultrasound devices. The company recently expanded its Acuson family of systems with new transducers designed for specialized cardiac and vascular applications. Siemens Healthineers engages in strategic partnerships with telehealth providers to enable remote ultrasound guidance for rural clinics. It prioritizes cybersecurity enhancements to protect patient data in connected imaging ecosystems. The company also supports professional education programs to train sonographers on advanced imaging techniques. These initiatives reinforce its commitment to precision medicine and expand its footprint in both institutional and outpatient care settings.

Top Strategies Used by the Key Market Participants

Key players in the North America ultrasound devices market primarily employ strategies focused on artificial intelligence integration and workflow automation to differentiate their offerings. Companies invest heavily in research and development to create smart algorithms that assist clinicians in image acquisition and interpretation. Strategic partnerships with health systems and telemedicine providers are common to expand reach into remote and underserved areas. Manufacturers also prioritize cybersecurity measures to protect sensitive patient data in increasingly connected devices. Product portability is another major focus with firms developing handheld units for point of care use. Additionally companies engage in continuous professional education to build loyalty among sonographers and radiologists. These multifaceted approaches enable sustained growth and deeper market penetration in a highly competitive landscape.

MARKET SEGMENTATION

This research report on the North American ultrasound devices market has been segmented and sub-segmented into the following categories.

By Technology

• Diagnostic Ultrasound
  • 2D Ultrasound
  • 3D & 4D Ultrasound
  • Doppler Ultrasound
• Therapeutic Ultrasound
  • High-intensity Focused Ultrasound
  • Extracorporeal Shockwave Lithotripsy

By Portability

• Trolley/Cart-based
• Compact/Handheld

By Device Display

• Colour
• Black and White

By Application

• Radiology/General Imaging
• Cardiology
• Obstetrics/Gynaecology
• Vascular
• Urology
• Other Applications

By Country

• The United States
• Canada
• Rest of North America